1. O-006Genomic profiling of diffuse gastric carcinoma (DGC). (2nd July 2019) Authors: Hemmerich, A; Madison, R; Klempner, S; Sokol, E; Severson, E; Miller, V; Lee, J; Ou, S; Alexander, B; Schrock, A; Ross, J; Ali, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O-019Comprehensive genomic profiling (CGP) defines the genomic landscape of colorectal cancer (CRC) in individuals of African ancestry. (2nd July 2019) Authors: Myer, P; Lee, J; Madison, R; Newberg, J; Ross, J; Chung, J; Albacker, L; Alexander, B; Miller, V; Schrock, A; Mitchell, E; Frampton, G; Ali, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. O-009Landscape of FMS-like tyrosine kinase 3 (FLT3) and associated molecular alterations in 44, 766 gastrointestinal (GI) cancers. (2nd July 2019) Authors: Salem, M; Juckett, L; Schrock, A; Ross, J; Puccini, A; Grothey, A; Lee, J; Miller, V; Madison, R; Ali, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 866PDComprehensive biomarker analyses and updated results of PURE-01 study: Neoadjuvant pembrolizumab (pembro) in muscle-invasive urothelial bladder carcinoma (MIBC). (23rd October 2018) Authors: Necchi, A; Briganti, A; Raggi, D; Luciano, R; Colecchia, M; Massa, S; Giannatempo, P; Colombo, R; Gallina, A; Salvioni, R; Mortarini, R; Montorsi, F; Madison, R; Ali, S M; Ross, J S; Chung, J; Anichini, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1649PA pan-cancer landscape analysis reveals a subset of endometrial stromal and pediatric tumors defined by internal tandem duplications of BCOR. (23rd October 2018) Authors: Juckett, L; Lin, D I; Madison, R; Patriquin, C; Frampton, G M; Miller, V A; Ross, J S; Chung, J; Schrock, A B; Ali, S M; Elvin, J A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 457PDKinase fusions in colorectal cancers: A unique biologic subset. (23rd October 2018) Authors: Madison, R; Pietrantonio, F; Juckett, L; Cremolini, C; Chung, J; Albacker, L A; Miller, V A; Klempner, S J; Resnick, M B; Yakirevich, E; Ou, S -H I; Fakih, M; Schrock, A B; Ross, J S; Ali, S M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 31P Development of a biomarker-based calculator to predict the probability to achieve a pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer. (15th December 2019) Authors: Marandino, L; Bandini, M; Madison, R; Raggi, D; Gallina, A; Colecchia, M; Lucianò, R; Giannatempo, P; Farè, E; Pederzoli, F; Bianchi, M; Colombo, R; Capitanio, U; Ali, S M; Chung, J H; Ross, J; Salonia, A; Briganti, A; Montorsi, F; Necchi, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 905PDMultiple-cohort analysis investigating FGFR3 alteration as a predictor of non-response to neoadjuvant pembrolizumab (pembro) in muscle-invasive bladder cancer (MIBC). (1st October 2019) Authors: Necchi, A; Madison, R; Chung, J; Raggi, D; Briganti, A; Montorsi, F; Boormans, J L; Liu, Y; De Jong, J J; Chung, J; Black, P C; Ross, J S; Ali, S M; Davicioni, E; Gibb, E A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗